Clinical trial
The Validation of a Novel Adherence Method for Oral Oncolytics
NCT03561272 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Validation of a Novel Adherence Method for Oral Oncolytics
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 20, 2017
- Completion date
- October 31, 2018
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer